Use of Recombinant, Activated Factor VII in the Treatment of Congenital Factor VII Deficiencies

Mariani, Giuliano; Testa, M.G.; Di Paolantonio, T.; Bech, Rikke; Hedner, Ulla; hoc Study Group, ad

doi:10.1046/j.1423-0410.1999.7730131.x

Public

Use of Recombinant, Activated Factor VII in the Treatment of Congenital Factor VII Deficiencies

Published in Vox Sanguinis • Oct 1, 1999

Authors:

Giuliano Mariani

M.G. Testa

T. Di Paolantonio

Abstract

Abstract Background and Objectives: Factor VII (FVII) deficiency is a rare coagulation disorder, historically treated with prothrombin complex concentrates or plasma‐derived FVII concentrates. We treated such patients (n=17) with a recombinant, activated FVII preparation. Materials and Methods: Twen...

View

Paywalled

Subject

Factor VII

Medicine

Coagulation

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Subject

Generate AI Take for this paper

Discussions